Inventor · disambiguated record
Dorothee Foernzler
Also filed as: FOERNZLER DOROTHEE
0 granted patents·20 pending applications·0 citations·filing 2001–2014
Top patents by PatentIndex Score
20 records- 0154US2014302019A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0251US2013183303A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0351US2013121999A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0451US2013183301A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0551US2013195857A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0651US2013183302A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0751US2013108626A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0848US2009286235A1Mdr1 Snp in Acute RejectionESSIOUX LAURENT·Filed 2006·Application pending·0 cites
- 0948US2010092947A1Impdh2 snp associated with acute rejectionESSIOUX LAURENT·Filed 2006·Application pending·0 cites
- 1048US2009286234A1Il10 snp associated with acute rejectionESSIOUX LAURENT·Filed 2006·Application pending·0 cites
- 1145US2013177554A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1245US2013183304A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1345US2013171134A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1445US2006228752A1Genetic polymorphisms in the preprotachykinin geneFOERNZLER DOROTHEE·Filed 2006·Application pending·0 cites
- 1542US2003158187A1Genetic polymorphisms in the preprotachy kinin geneFiled 2003·Application pending·0 cites
- 1642US2014099302A1Methods to identify responsive patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1742US2004076968A1Method for detecting pre-disposition to hepatotoxicityFiled 2001·Application pending·0 cites
- 1836US2011182892A1Methods to identify responsive patientsHOFFMANN LA ROCHE·Filed 2011·Application pending·0 cites
- 1932US2012195858A1Responsiveness to angiogenesis inhibitorsFOERNZLER DOROTHEE·Filed 2010·Application pending·0 cites
- 2029US2004132021A1Osteolevin gene polymorphismsBALEMANS WENDY·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dorothee Foernzler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →